Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.
Examination of the Chicago Multiscale Depression Inventory and Initial Validation of a Positive Scale.
Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
There is no evidence to support or refute the effectiveness of memory rehabilitation on memory function or functional abilities in people with multiple sclerosis.
Enhanced accumulation of Kir4.1 protein, but not mRNA, in a murine model of cuprizone-induced demyelination.
Pharmacological treatment for memory disorder in multiple sclerosis.
Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis.
Autoimmune disease preceding amyotrophic lateral sclerosis: An epidemiologic study.
Assessments of nursing home guidelines for quality of care provided to residents with multiple sclerosis.
Oropharyngeal dysphagia in multiple sclerosis.
Environmental Enrichment Stimulates Immune Cell Secretion of Exosomes that Promote CNS Myelination and May Regulate Inflammation.
Does the preclinical evidence for functional remyelination following engraftment into the injured spinal cord support progression to clinical trials?
1,25-dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation.
The clinical features and diagnosis of Metachromatic leukodystrophy: A case series of Iranian Pediatric Patients.
Fibrillary glomerulonephritis combined with chronic inflammatory demyelinating polyneuropathy.
Expression of Kir4.1 and Kir5.1 inwardly rectifying potassium channels in oligodendrocytes, the myelinating cells of the CNS.
Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis.
Cortical plasticity predicts recovery from relapse in multiple sclerosis.
Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis.
Human polyoma JC virus minor capsid proteins, VP2 and VP3, enhance large T antigen binding to the origin of viral DNA replication: Evidence for their involvement in regulation of the viral DNA replication.
Multiple sclerosis: Reprogramming the immune repertoire with alemtuzumab in MS.
Assessment of the effect of cigarette smoking on regional brain volumes and lesion load in patients with clinically isolated syndrome.
Body mass index underestimates adiposity in persons with multiple sclerosis.
Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis.
Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments.
Pages
« first
‹ previous
…
697
698
699
700
701
702
703
704
705
…
next ›
last »